Clinical profiles and diagnostic challenges in 1158 children with rare hepatobiliary disorders
Top Cited Papers
- 12 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pediatric Research
- Vol. 89 (1), 238-245
- https://doi.org/10.1038/s41390-020-0888-4
Abstract
Background Diagnosis of rare diseases possesses a great challenge in pediatric hepatology because expert knowledge in the field is extremely insufficient. The study aims to explore new findings and collect diagnostic experience from pediatric rare liver diseases. Methods The large-sample case analysis study included pediatric patients who had liver-involved rare diseases. All cases underwent liver biopsy and/or gene sequencing. Results A total of 1158 pediatric patients were identified. Liver-based genetic diseases were most frequent (737 cases), followed by liver damages involved in extrahepatic or systemic disorders (151 cases) and cryptogenic hepatobilliary abnormalities (123 cases). Of note, diagnoses of 16 patients were re-evaluated according to genetic results combined with clinical pointers. In addition, 101 patients who underwent gene sequencing remained undiagnosed. Of them, 55 had negative genetic findings, 30 harbored mutations that failed to meet their typically pathogenic condition, and 16 had detected variants that were inconsistent with clinical pointers. Conclusions As a study involving known largest number of children with rare hepatobiliary disorders, it allows us to accumulate information (especially new findings) on the etiology and diagnosis of these disorders. The results can help to improve the diagnostic quality in the population. Impact Liver-based genetic diseases were most frequent in clinical profiles of pediatric rare liver diseases. Some novel variants in cases with genetic diseases (for example, two variants of c.3638G>T and c.1435G>C in a patient with progressive familial intrahepatic cholestasis type 2) were identified. As a study involving known largest number of pediatric cases with rare hepatobiliary disorders, it allows us to accumulate information on the etiology and diagnosis of these disorders. The study can help to optimize the diagnostic process and significantly improve the diagnostic quality in the field of pediatric hepatology. Given that clinical variability often exists within rare genetic disease entities and not all rare disorders are genetic, clinicians should not over-depend on the genetic results in the diagnosis.This publication has 39 references indexed in Scilit:
- Model Organisms Facilitate Rare Disease Diagnosis and Therapeutic ResearchGenetics, 2017
- The coming of age of a young subspecialty: paediatric hepatologyActa Paediatrica, 2017
- Young adults with paediatric liver disease: future challengesArchives of Disease in Childhood, 2016
- Variation Interpretation Predictors: Principles, Types, Performance, and ChoiceHuman Mutation, 2016
- From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulationAnnals of the New York Academy of Sciences, 2016
- Pediatric liver diseases: current challenges and future perspectivesExpert Review of Gastroenterology & Hepatology, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Reloading Against Rare Liver DiseasesJournal of Pediatric Gastroenterology and Nutrition, 2010
- A sensitive and simplified method to analyze free fatty acids in children with mitochondrial beta oxidation disorders using gas chromatography/mass spectrometry and dried blood spotsClinica Chimica Acta; International Journal of Clinical Chemistry, 2002
- Screening for fatty acid beta oxidation disorders: Acylglycine analysis by electron impact ionization gas chromatography–mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1999